The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Sep. 05, 2023
Filed:
May. 06, 2022
Applicant:
Gilead Sciences, Inc., Foster City, CA (US);
Inventors:
Benjamin Micah Collman, San Mateo, CA (US);
Lei Hong, Cupertino, CA (US);
Joanna M. Koziara, Foster City, CA (US);
Assignee:
Gilead Sciences, Inc., Foster City, CA (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/5365 (2006.01); A61K 9/24 (2006.01); A61K 9/20 (2006.01); A61K 31/513 (2006.01); A61K 31/675 (2006.01); A61K 31/553 (2006.01); A61P 31/18 (2006.01); A61K 9/28 (2006.01); A61K 31/537 (2006.01); A61K 9/00 (2006.01);
U.S. Cl.
CPC ...
A61K 9/209 (2013.01); A61K 9/0053 (2013.01); A61K 9/2013 (2013.01); A61K 9/2027 (2013.01); A61K 9/2054 (2013.01); A61K 9/2086 (2013.01); A61K 9/2095 (2013.01); A61K 9/28 (2013.01); A61K 9/2833 (2013.01); A61K 31/513 (2013.01); A61K 31/537 (2013.01); A61K 31/5365 (2013.01); A61K 31/553 (2013.01); A61K 31/675 (2013.01); A61P 31/18 (2018.01);
Abstract
A solid oral dosage form is provided, comprising a compound of Formula I or a pharmaceutically acceptable salt thereof, tenofovir alafenamide or a pharmaceutically acceptable salt thereof, and emtricitabine or a pharmaceutically acceptable salt thereof.